ABclonal Logo Rectangle on white-01.png
ABclonal Technology Partners with BenchSci to Boost Discoverability of its Novel Products
February 25, 2019 08:45 ET | ABclonal Technology
BOSTON, Feb. 25, 2019 (GLOBE NEWSWIRE) -- ABclonal Technology, a new and growing provider of biology research reagents and services, and BenchSci, a life science machine learning company backed by...
20170406 Telix Logo.png
Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics
November 28, 2018 18:17 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
20170406 Telix Logo.png
テリックスと日本メジフィジックスが アクチニウム標識腎癌治療薬の開発を目指した技術提携契約を締結
November 28, 2018 18:17 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited(本社:オーストラリア メルボルン、CEO:Dr. Christian...
Advanced Proteome logo.jpg
Advanced Proteome Therapeutics Reports Progress on Collaboration with Noria Pharmaceuticals
October 15, 2018 08:30 ET | Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to announce the successful...
Akers Bio logo
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
October 08, 2018 02:00 ET | Akers Biosciences Inc
THOROFARE, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Logo-BCC-Research.jpg
Global Markets for Research Antibodies to Reach $3.0B by 2022
January 16, 2018 06:30 ET | BCC Research
WELLESLEY, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Dramatic change in leading antibody manufacturing technologies is spurring growth in research antibodies, which have the potential to comprise a...
ContraFect Corporation Announces Issuance of Patent for Novel Approach to Treat Influenza Using Inhaled Antibodies
August 03, 2017 16:01 ET | ContraFect Corporation
YONKERS, NY--(Marketwired - August 03, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
"Speak What You Think, So I Can Learn"
April 16, 2015 14:11 ET | ARUP Laboratories
SALT LAKE CITY, April 16, 2015 (GLOBE NEWSWIRE) -- The go-to-book for body fluids, Kjeldsberg's Body Fluid Analysis (4th edition)was recently updated and released by the American Society for Clinical...
Avid Bioservices to Highlight Novel Methods for Increasing Protein Expression and Developing an Optimized Upstream Process at IBC's Biopharmaceutical Development & Production Week Conference
March 24, 2014 15:23 ET | Avid Bioservices
TUSTIN, CA--(Marketwired - Mar 24, 2014) - Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc., today announced that recent studies evaluating a new suspension...
Avid Bioservices to Present Two Successful Case Studies Highlighting Development and Manufacturing Expertise That Supports Commercial Production at Upcoming Industry Events
September 11, 2013 19:55 ET | Avid Bioservices
TUSTIN, CA--(Marketwired - Sep 11, 2013) - Avid Bioservices, Inc., a subsidiary of Peregrine Pharmaceuticals, Inc., today announced presentations at the following upcoming industry events: ...